An interventional study of Improvisational Music Therapy in Autism, sponsored by Prof Simon Baron-Cohen. Recruiting at 2 sites in United Kingdom. Open to participants aged 7 Years to 11 Years. Per ClinicalTrials.gov, last updated 2025-03-25.
Sponsored by Prof Simon Baron-Cohen · Not applicable, Interventional, and Treatment
How we know · 2 judgments
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 37 studies in Autistic Disorder with a site in United Kingdom — 10 open to participants now, 14 under way, none of them phase 3. Autistic Disorder · United Kingdom.
Among the 37 studies in Autistic Disorder with a site in United Kingdom, this one is the 2nd largest by planned enrollment of the 21 interventional ones that give a count, is one of 5 that started in 2023, is one of 19 with no phase, reaches primary completion later than 6 of the 13 other live ones, and was the 24th registered.
1,035 studies on the registry are indexed under Autistic Disorder; 270 are open to participants now.
Browse Autistic Disorder studies →10 of the 37 studies in Autistic Disorder with a site in United Kingdom are open now. Recruiting first, the newest first:
Canterbury Christ Church University · Sites in United Kingdom
Ages 18+
University of Reading · Sites in United Kingdom
Ages 18–60
University of Manchester · Sites in United Kingdom
Ages 11–16
Aberystwyth University · Sites in United Kingdom
Ages 10–24 · Healthy volunteers
Sussex Community NHS Foundation Trust · Sites in United Kingdom
Ages 6–16
A study can be open while its sites in United Kingdom have not opened yet or have stopped. Only those recruiting at a site in United Kingdom →
Of the 184 Autistic Disorder studies recruiting now, 33 (18%) set no upper age limit and 144 (78%) stop at 75 or younger; 150 take children under 18; 56 take healthy volunteers.
This study: 7 Years to 11 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
37 studies; the count open now beside each. This study's row is marked.
First in 2011; this study’s year is marked. 5 started in 2023.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 240 is above the median of 50 across 814 interventional studies indexed under Autistic Disorder.
Median enrollment 69 across the 21 interventional studies, 163 across the 16 observational. Of the 20 that completed or were terminated, 3 (15%) have results posted.
This tab as a report to print or save as PDF → With an account.
2 of 37 have an industry lead sponsor. The 10 most frequent:
This is the only study on the registry with Prof Simon Baron-Cohen as lead sponsor.
Prof Simon Baron-Cohen has 1 study filed under Autistic Disorder — fewer than ten, so there is no comparison to draw.
2 of the studies in Autistic Disorder with a site in United Kingdom that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07498049University of NottinghamCFT Guided Self-help Intervention: Parents of Autistic Children | 2026-11 |
| NCT07630376Canterbury Christ Church UniversityEvaluating a Workbook to Promote Autistic Wellbeing | 2027-03 |
Add all 2 to your calendar (.ics) → With an account.
Among the 37 studies in Autistic Disorder with a site in United Kingdom, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this clinical trial is to evaluate the effectiveness of individual sessions of improvisational music therapy for autistic children aged 7 - 11.
Researchers will compare the impact of adding improvisational music therapy to usual care alone for autistic children over a 12-week period.
Participants will be randomly assigned to one of the following two conditions: the Improvisational Music Therapy (intervention) Group or the support as usual (control) Group.
The aim is to achieve seven overarching objectives:
Co-Chief Investigators Professor Simon Baron-Cohen Dr Carrie Allison Dr David M. Greenberg Dr. Jonathan Pool
Co-Investigators Dr Artur Jaschke
Advisor Emeritus Professor Helen Odell-Miller Dr. Claire Howlin
The Autism-CHIME trial is designed as a rigorous Randomised Controlled Trial (RCT) of individual sessions of improvisational music therapy with autistic children. The trial will be conducted in mainstream and special schools located in Cambridgeshire, Peterborough, London, and the South and East of England. The number of schools involved will depend on the number of eligible children willing to participate, with a minimum of 5-10 children per school.
Enrolled participants will undergo 1:1 block randomisation, to either support as usual plus improvisational music therapy sessions (intervention arm) or support as usual (control arm). Randomisation will occur after the baseline assessments have been completed. Participants will be stratified based on the version of the Brief Observation of Social Communication Change (BOSCC) that they are allocated (primary outcome measure): (1) Minimally Verbal, (2) Phrase Speakers, or (3) Fluent Speakers, so that there are equal numbers in each group, and that the control group and experimental group are balanced.
Data will be collected at different time points during the trial:
The first data collection point (T1) will be collected prior to randomisation (to establish eligibility to participate and assess baseline functioning), and at the primary endpoint T2 (13 weeks after randomisation; end of intervention) and the secondary endpoint T3 will be 39 weeks post-randomisation (i.e. 6 months after the end of music therapy).
The trial will finish after the final follow-up data collection from the participants is completed.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants allocated to 'support as usual' will receive routine support from their general practitioners (GPs), mental health and education/allied health professionals. Support as usual is defined as normal practice for each school in addition to the usual support from the specialist teaching teams for autism in the area, or any other additional therapies intended to support communication skills or wellbeing for autistic children. They will not receive the individual music therapy intervention or any extra support services from the research team. Any concomitant treatment or therapeutic interventions that participating children might receive will be recorded during assessment sessions before randomisation, and following the primary endpoint, specifying the kind and amount or frequency of intervention.
Participating children randomised to the Improvisational Music Therapy (intervention) Group will receive 30-minute individual music therapy sessions two times per week over a 12-week period. These will be delivered by academically trained Health and Care Professions Council (HCPC)-registered music therapists in the United Kingdom (master's level or equivalent) with clinical experience of working with autistic children. Each child in the intervention arm will receive 24 sessions of music therapy over a 12-week period. A music therapy training manual will be used to guide music therapists.
Behavioral: Improvisational Music Therapy
The therapist engages with the child by playing and sharing musical instruments, and/or sings while being attuned to the child's behaviour and expression. Various improvisational techniques are employed to engage the child. There are opportunities for pulse, rhythmic, dynamic or melodic patterns, and timbre to be mirrored, reinforced, or complemented, which allows for moments of synchronization between the therapist and the child, giving the child's musical expressions a pragmatic meaning within this context. The therapist may also gently provoke the child by violating expectations or patterns that have been jointly developed in order to elicit specific social communication behaviours. Further, there are opportunities for the child to develop and enhance social communication skills such as joint attention, sharing affect, reciprocity, shared history, scaffolding, imitation and turn-taking. These have been shown to develop social competency and also resilience.
Absolute change of the total score of the Brief Observation of Social Communication Change (BOSCC). One of three versions of the BOSCC will be used depending on the child's level of verbal communication.
The BOSCC consists of specific items that were developed to identify changes in social-communication behaviours over relatively short periods of time by quantifying subtleties in both the frequency and the quality of specific behaviours. There are three forms of the BOSCC: one for individuals who are minimally verbal (MV), one for those with phrase speech/young fluent speakers (PS/YF up to age 6 - 8) and one for fluent speakers (F1/F2 with two sets of materials, one for children and one for adolescents and adults). Scores are based on the observation of social communicative behaviour during naturalistic interactions between a child and an adult.
Time frame: Baseline and at the end of intervention (13 weeks after randomisation).
Absolute change of the total score of the BOSCC.
The BOSCC consists of specific items that were developed to identify changes in social-communication behaviours.
Time frame: Baseline and 39 weeks after randomisation.
Absolute change of the total score of the Children's Communication Checklist-2 to test improvement in communication skills.
Measure designed to assess the communication skills of children 4 to 16. It includes two domains: Language (Speech, Syntax, Semantics, Coherence) and Pragmatics (Initiation, Scripted Language, Context, Nonverbal Communication, Social Relations, Interests).
Time frame: Baseline, 13 and 39 weeks after randomisation.
Absolute change of the total score of the Strengths and Difficulties Questionnaire to test improvement in psychosocial difficulties
Questionnaire of behavioural and emotional difficulties suitable for children aged 3-16 years old. It addresses different dimensions: emotional problems, conduct problems, hyperactivity/inattention problems, peer problems and prosocial behaviour.
Time frame: Baseline, 13 and 39 weeks after randomisation.
Absolute change of the total score of the Young Child Outcome Rating Scale (YCORS) as a measure of wellbeing.
Engaging young children regarding their assessment of how they are doing using child friendly language (faces).
Time frame: Baseline, 13 and 39 weeks after randomisation.
Absolute change of the total score of the Vineland-3 Domain level parent/caregiver form to test improvement in adaptive functioning.
Measure of adaptive functioning including Communication domain, Daily living skills domain and Socialization domain.
Time frame: Baseline, 13 and 39 weeks after randomisation.
Absolute change of the total score of the Parent-Rated Anxiety Scale (PRAS) for Youth with Autism Spectrum Disorder (ASD) as a measure of anxiety.
The PRAS-ASD is a 25-item, parent-reported measure of anxiety symptoms in youth with ASD (age 5-17 years).
Time frame: Baseline, 13 and 39 weeks after randomisation.
Association between the therapeutic relationship and the development of social, communication and language skills.
The therapeutic relationship will be measured using the Assessment of the Quality of Relationship (AQR), based on video recordings of the first and last of music therapy to evaluate the association between the therapeutic relationship and the development of social, communication and language skills in children allocated to the music therapy intervention.
Time frame: Weeks 1 and 12
Absolute change of the total score of the Music Therapy Communication and Social Interaction Scale (MTCSI) (or Music Engagement Scale, MES) based on video recordings.
Measured based on video recordings of the first and last weeks of music therapy in all of the children allocated to the music therapy intervention) to evaluate communicative and socially interactive responses that are elicited during music therapy sessions.
Time frame: Weeks 1 and 12.
Plan to share: No
Started Nov 2023 (actual). Primary completion is estimated for Dec 2025, 25 months after the start.
Of 355 non-industry interventional studies with no phase under Autistic Disorder, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 50. This study's planned 25 months is close to that.
Counting every sponsor, half of 367 studies reached it within 26 months; a quarter within 13 and three quarters within 50.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.